SCOTT KANE: Open Payments
NPI 1265625313 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 4 payments from 4 companies in 2025. Trend: 2023 $607 · 2024 $100 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $136 |
| Lilly USA, LLC | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $113 |
| Novo Nordisk Inc | 1 | $111 |
Products named: INGREZZA, ZEPBOUND, CAPLYTA, Wegovy.
Industry payments across FL — which companies pay providers there.
